The psychiatrist used to have to stay with the patient during their entire session. Now they’ll be able to leave the room after administering the drug.
Articles on MDMA
Displaying 1 - 20 of 64 articles
Doctors working in palliative care see promise in emerging therapies involving psychedelic drugs, but say many questions still need to be addressed.
Wastewater data can only measure the volume of drugs consumed, not the number of people using them or the level of harm they experience.
Legal drugs mimic popular substances. But when one is banned, another quickly takes its place.
Psychedelic-assisted therapy offers promise. But new research highlights concerns about safety and accessibility.
Psychedelics are marketed as a way for the general population to extract more work out of their already overworked lives, and to be happy about it in the process.
MDMA, psilocybin, ketamine derivatives, and other hallucinogens are authorised in certain countries to treat depression or post-traumatic stress disorder. What is the level of evidence?
The FDA’s decision shines a light on some of the unique obstacles that psychedelic drugs may face on the path to approval.
Pharmaceutical giants like Johnson & Johnson as well as smaller startups are investing in psychedelic drug development, and both are pursuing FDA approval for their patented psilocybin formulations.
Cocaine and other illicit drugs have been found to be contain nitazenes, a dangerous class of synthetic opioids.
One in seven Canadian veterans is living with PTSD. Developing a psychedelics research program for veterans should be a public health priority.
Taking MDMA can raise our body temperature higher than it should be. Extreme heat may compound this effect.
Clinical psychologist and professor Monnica Williams is on a mission to bring psychedelics to therapists’ offices to help people heal from their racial traumas. To do this, she’s jumping over some big hurdles.
From July 1, authorised psychiatrists will be able to prescribe MDMA and psilocybin in some circumstances. Here’s what we’re excited and concerned about.
Australia is the first country in the world to legalise the medical use of psychedelics. But without a public subsidy, few Australians will be able to afford them.
Receiving a cancer diagnosis and undergoing cancer treatment can be a traumatizing experience. Psychedelics like LSD, psilocybin and MDMA could help alleviate symptoms from cancer-related PTSD.
The early research suggests the drugs might be effective for some conditions. But scientists have safety concerns.
From July this year, some psychiatrists will be able to prescribe psychedelics to some patients. Responses from experts working in the field are mixed.
As British Columbia begins a new era in drug policy, the drug poisoning crisis continues without an end in sight.
Alberta’s new policy on psychedelic-assisted therapy for mental illness may set a precedent that moves Canadians one step closer to accepting psychedelics as medicinal substances.
Top contributors
-
Adjunct Professor at the National Drug Research Institute (Melbourne based), Curtin University
-
Associate Professor, National Drug Research Institute / enAble Institute, Curtin University
-
Senior Lecturer of Addiction, Edith Cowan University
-
Research fellow, Swinburne University of Technology
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Associate Professor of Population Health, New York University
-
Honors Faculty Fellow, Associate Teaching Professor, and Associate Director of the Center for Work & Democracy, Arizona State University
-
Senior lecturer, Australian National University
-
Professor and Canada Research Chair in the History of Health & Social Justice, University of Saskatchewan
-
Professor of Neuropsychopharmacology, Imperial College London
-
Professor in Substance Use, Liverpool John Moores University
-
Lecturer, RMIT University
-
Professor of Neuroimaging & Psychopharmacology, King's College London
-
Senior Lecturer in Chemistry, University of Birmingham
-
Research Fellow, University of Queensland, The University of Queensland